Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Maintenance Therapy With Histamine Dihydrochloride and Interleukin-2 in Adult Acute Myeloid Leukemia (AML) Patients With Measurable Minimal Residual Disease (MRD)- a Non-interventional Study (NIS)

NCT01770158 is registered in ClinicalTrials.gov with University of Ulm as lead sponsor.

NCT NCT01770158
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01770158 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Maintenance Therapy With Histamine Dihydrochloride and Interleukin-2 in Adult Acute Myeloid Leukemia (AML) Patients With Measurable Minimal Residual Disease (MRD)- a Non-interventional Study (NIS)
Lead sponsor
University of Ulm
Phase
Observational
Overall status
Terminated
Start date
October 31, 2012
Completion date
March 27, 2018
Enrollment
8 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia